Richard Hammond

The bioeconomy – economic activity built on biology – is growing rapidly across the globe. New technology to predict and control biology is driving change in industries from pharmaceuticals to energy.

Core to commercialising any successful technology is the ability to measure and characterise. As our ambitions to manipulate biology grow, the challenge of how to measure such complex systems also grows. How do we characterise the biology products of the future? How hard can it be?

This seminar investigates issues in measuring biological systems and discusses new techniques – such as using biology to measure biology – that support truly smarter products.

Media downloads

A1 Measuring biology how hard can it be.pdf
Author
Richard Hammond
Technology Director and Head of Synthetic Biology

Richard is a Director in the Medical Technologies Division and leads Cambridge Consultants' work in synthetic biology. Since graduating from University of Cambridge in the mid-nineties, Richard has worked extensively in life sciences developing novel products and processes for both research and clinical applications.